Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/OBD stock hub

AIM/OBD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/OBDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.7M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/OBD

In the news

Latest news · AIM/OBD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-407.5

P25 -54.2P50 2.1P75 13.7

ROIC-82.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/OBD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

GBP

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	41
Employees Change	-10%
Employees Change Percent	-19.61
Enterprise value	GBX 11.4M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BD5H8572
Last refreshed	2026-05-10
Market cap	GBX 7.7M
Price	GBX 0.18
Price currency	GBX
Rev Per Employee	26,707.32x
Sector	Healthcare
Sic	2835
Symbol	aim/OBD
Website	https://www.oxfordbiodynamics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-144.4%
EV Earnings	-1.03x
EV/FCF	-1.51x
EV/Sales	10.45x
FCF yield	-98.27%
P/B ratio	6.92x
P/S ratio	7.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	47.67%
Gross Profit	GBX 522,000
Gross Profit Growth	13.23%
Gross Profit Growth Q	39.35%
Gross Profit Growth3 Y	26.81%
Gross Profit Growth5 Y	24.43%
Net Income	GBX -11.2M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-1,043.11%
Profit Per Employee	GBX -272,024
ROA	-66.52
Roa5y	-47.42
ROCE	-196.1
ROE	-407.5
Roe5y	-218.4
ROIC	-82.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-55.02%
Cagr3y	-77.56%
Cagr5y	-70.32%
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth	72.17x
Revenue Growth Q	64.4x
Revenue Growth Quarters	6x
Revenue Growth Years	3x
Revenue Growth3 Y	21.07x
Revenue Growth5 Y	30.53x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.11
Assets	GBX 8.1M
Cash	GBX 1.4M
Current Assets	GBX 2.3M
Current Liabilities	GBX 2.6M
Debt	GBX 5.1M
Debt Equity	GBX 4.58
Debt FCF	GBX -0.67
Equity	GBX 1.1M
Interest Coverage	-34.78
Liabilities	GBX 7M
Long Term Assets	GBX 5.8M
Long Term Liabilities	GBX 4.4M
Net Cash	GBX -3.7M
Net Cash By Market Cap	GBX -48.15
Net Debt Equity	GBX 3.33
Tangible Book Value	GBX 10,000
Tangible Book Value Per Share	GBX 0
WACC	3.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.88
Inventory Turnover	2.22
Net Working Capital	GBX -429,000
Quick ratio	0.76
Working Capital	GBX -325,000
Working Capital Turnover	GBX 1.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-442.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-55%
200-day SMA	0.33
3Y total return	-98.87%
50-day SMA	0.22
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.77%
All Time High	278.8
All Time High Change	-99.94%
All Time High Date	2017-10-20
All Time Low	0.17
All Time Low Change	5.88%
All Time Low Date	2026-05-08
ATR	0.02
Beta	-0.19
Beta1y	-0.77
Beta2y	-0.4
Ch YTD	-16.28
High	0.2
High52	0.78
High52 Date	2025-07-16
High52ch	-76.92%
Low	0.17
Low52	0.17
Low52 Date	2026-05-08
Low52ch	5.88%
Ma50ch	-18.81%
Price vs 200-day SMA	-45.44%
RSI	32.25
RSI Monthly	33.06
RSI Weekly	33.87
Sharpe ratio	0.1x
Sortino ratio	0.27
Total Return	-442.4%
Tr YTD	-16.28
Tr1m	-7.69%
Tr1w	-12.2%
Tr3m	-35.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -10.7M
Operating margin	-981.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,065,164,527%
Net Borrowing	-656,000
Shares Insiders	1.44%
Shares Institutions	70.02%
Shares Out	4,290,910,967
Shares Qo Q	126.07%
Shares Yo Y	442.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -8.1M
Average Volume	8,109,631.85x
Bv Per Share	0
CAPEX	GBX -17,000
Ch1m	-7.69
Ch1w	-12.2
Ch1y	-55
Ch3m	-35.71
Ch3y	-98.87
Ch5y	-99.77
Ch6m	-40.98
Change	-2.7%
Change From Open	-7.22
Close	0.19
Days Gap	4.86
Depreciation Amortization	481,000
Dollar Volume	2,142,659.9
Earnings Date	2026-06-05
EBIT	GBX -10.7M
EBITDA	GBX -10.3M
EPS	GBX -0.01
F Score	2
FCF	GBX -7.6M
FCF EV Yield	-66.33x
FCF Per Share	GBX -0
Financing CF	6,325,000
Fiscal Year End	September
Founded	2,007
Income Tax	GBX -269,000
Investing CF	813,000
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-09-30
Ma150	0.28
Ma150ch	-35.51%
Ma20	0.21
Ma20ch	-14.73%
Net CF	-435,000
Next Earnings Date	2026-06-05
Open	0.19
Position In Range	33.33
Ppne	4,699,000
Price Date	2026-05-08
Ptbv Ratio	772.4
Relative Volume	1.47x
Revenue	1,095,000x
SBC By Revenue	45.75x
Share Based Comp	501,000
Tax By Revenue	-24.57x
Tr6m	-40.98%
Volume	11,903,666
Z Score	-12.68

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/OBD pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/OBD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/OBD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+70.0%

Share of float held by funds and institutions

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+442.4%

Negative means the company is buying back shares.

Technical

AIM/OBD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.3

Neutral momentum band

Price vs 200-day MA

-45.4%

50/200-day relationship not available

Beta (5Y)

-0.19

Less volatile than the market

Sharpe ratio

0.10

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/OBD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/OBD stock rating?

aim/OBD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/OBD analysis?

The full report lives at /stocks/aim/OBD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/OBD?

The latest report frames aim/OBD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/OBD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.